ADMA BIOLOGICS, INC. Payments of Debt Issuance Costs
ADMA BIOLOGICS, INC. (ADMA) reported Payments of Debt Issuance Costs of $2.22 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2025-11-05
- ADMA BIOLOGICS, INC. payments of debt issuance costs for the quarter ending 2020-12-31 was $0.00.
- ADMA BIOLOGICS, INC. payments of debt issuance costs for the quarter ending 2020-09-30 was $0.00.
- ADMA BIOLOGICS, INC. payments of debt issuance costs for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- ADMA BIOLOGICS, INC. payments of debt issuance costs for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- ADMA BIOLOGICS, INC. payments of debt issuance costs for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- ADMA BIOLOGICS, INC. payments of debt issuance costs for fiscal 2019 was $1.68M.
- ADMA BIOLOGICS, INC. payments of debt issuance costs for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- ADMA BIOLOGICS, INC. payments of debt issuance costs for fiscal 2017 was $1.65M, a 3403.25% increase from fiscal 2016.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2025-09-30 | $2.22M 10-Q · filed 2025-11-05 | |||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-05 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $0.00 derived: sum of 3 quarters · filed 2021-03-25 | $0.00 10-K · filed 2021-03-25 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | $0.00 derived: sum of 4 quarters · filed 2021-03-25 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $0.00 10-Q · filed 2020-08-05 | $0.00 derived: sum of 3 quarters · filed 2021-03-25 | $0.00 derived: sum of 4 quarters · filed 2021-03-25 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-06 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $0.00 derived: sum of 3 quarters · filed 2021-03-25 | $123.90K derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $123.90K derived: sum of 3 quarters · filed 2021-03-25 | $1.68M 10-K · filed 2021-03-25 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $123.90K derived: sum of 2 quarters · filed 2020-11-05 | $1.68M 10-Q · filed 2020-11-05 | $1.68M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $123.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $1.68M 10-Q · filed 2020-08-05 | $1.68M derived: sum of 3 quarters · filed 2020-08-05 | $1.68M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | $1.56M 10-Q · filed 2020-05-06 | $1.56M derived: sum of 2 quarters · filed 2020-05-06 | $1.56M derived: sum of 3 quarters · filed 2020-05-06 | $1.56M derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $0.00 derived: sum of 2 quarters · filed 2020-03-13 | $0.00 derived: sum of 3 quarters · filed 2020-03-13 | $0.00 10-K · filed 2020-03-13 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $0.00 10-Q · filed 2019-11-06 | $1.48M derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | $1.48M derived: sum of 3 quarters · filed 2019-08-08 | $1.48M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-08 | $1.48M derived: sum of 2 quarters · filed 2019-05-08 | $1.48M derived: sum of 3 quarters · filed 2019-05-08 | |
| 2017-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $1.48M derived: sum of 2 quarters · filed 2019-03-13 | $1.65M 10-K · filed 2019-03-13 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $174.84K 10-Q · filed 2018-11-09 | ||
| 2017-06-30 | $174.84K 10-Q · filed 2018-08-10 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $22.90K derived: sum of 2 quarters · filed 2018-03-29 | $47.10K 10-K · filed 2018-03-29 | |
| 2016-09-30 | $22.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $47.10K 10-Q · filed 2017-11-03 | ||
| 2016-06-30 | $24.20K 10-Q · filed 2017-08-11 | |||
| 2015-12-31 | $55.70K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $93.56K derived: sum of 2 quarters · filed 2017-02-24 | $228.06K derived: sum of 3 quarters · filed 2017-02-24 | $228.06K 10-K · filed 2017-02-24 |
| 2015-09-30 | $37.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $172.36K derived: sum of 2 quarters · filed 2016-11-10 | $172.36K 10-Q · filed 2016-11-10 | $172.36K derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | $134.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $134.50K 10-Q · filed 2016-08-12 | $134.50K derived: sum of 3 quarters · filed 2016-08-12 | $134.50K derived: sum of 4 quarters · filed 2016-08-12 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-12 | $0.00 derived: sum of 2 quarters · filed 2016-03-23 | $0.00 derived: sum of 3 quarters · filed 2016-03-23 | -$28.19K derived: sum of 4 quarters · filed 2016-03-23 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | $0.00 derived: sum of 2 quarters · filed 2016-03-23 | -$28.19K derived: sum of 3 quarters · filed 2016-03-23 | $30.14K 10-K · filed 2016-03-23 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | -$28.19K derived: sum of 2 quarters · filed 2015-11-10 | $30.14K 10-Q · filed 2015-11-10 | |
| 2014-06-30 | -$28.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | $30.14K 10-Q · filed 2015-08-11 | ||
| 2014-03-31 | $58.33K 10-Q · filed 2015-05-12 | |||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-10 | |||
| 2012-12-31 | $25.00K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |